Biogen Inc. (BIIB)
Biogen Max Pain By Strike
BIIB trades at $138.87, 3.6% above the near-term max pain of $134 expiring Aug 22, 2025 (2 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($120-$145), indicating stable market expectations. Key magnetic zone at 130 where 3 expirations converge.
Biogen Max Pain By Expiry
Max pain for BIIB shows stable levels around 132.29, reflecting balanced market expectations. The 19% spread signals divergent expectations across timeframes. Most levels below 138.87 may cap rallies. Strong magnetic level at 130 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 22, 2025 | 134 | -4.87 (-3.51%) |
| Aug 29, 2025 | 125 | -13.87 (-9.99%) |
| Sep 5, 2025 | 132 | -6.87 (-4.95%) |
| Sep 12, 2025 | 136 | -2.87 (-2.07%) |
| Sep 19, 2025 | 120 | -18.87 (-13.59%) |
| Sep 26, 2025 | 135 | -3.87 (-2.79%) |
| Oct 17, 2025 | 130 | -8.87 (-6.39%) |
| Jan 16, 2026 | 125 | -13.87 (-9.99%) |
| Mar 20, 2026 | 130 | -8.87 (-6.39%) |
| Apr 17, 2026 | 140 | 1.13 (0.81%) |
| Jun 18, 2026 | 130 | -8.87 (-6.39%) |
| Sep 18, 2026 | 135 | -3.87 (-2.79%) |
| Dec 18, 2026 | 145 | 6.13 (4.41%) |
| Jan 15, 2027 | 135 | -3.87 (-2.79%) |